These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8745824)

  • 1. [Severe parvovirus B19 infection in an immunocompetent child with hemophilia A].
    Coumau E; Peynet J; Harzic M; Béal G; Castaigne S; Leverger G; Foucaud P
    Arch Pediatr; 1996 Jan; 3(1):35-9. PubMed ID: 8745824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Life-threatening human parvovirus B19 infection in immunocompetent haemophilia.
    Yee TT; Lee CA; Pasi KJ
    Lancet; 1995 Mar; 345(8952):794-5. PubMed ID: 7605434
    [No Abstract]   [Full Text] [Related]  

  • 3. Transmission of human parvovirus B19 by plasma derived factor VIII concentrates.
    Laurian Y; Dussaix E; Parquet A; Chalvon-Demersay A; d'Oiron R; Tchernia G
    Nouv Rev Fr Hematol (1978); 1994 Dec; 36(6):449-53. PubMed ID: 7753615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B19 parvovirus DNA in solvent/detergent-treated anti-haemophilia concentrates.
    Lefrère JJ; Mariotti M; Thauvin M
    Lancet; 1994 Jan; 343(8891):211-2. PubMed ID: 7904670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological and virological markers of human parvovirus B19 infection in sera of hemophiliacs.
    Grosse-Bley A; Eis-Hübinger AM; Kaiser R; Oldenburg J; Brackmann HH; Schwarz TF; Schneweis KE
    Thromb Haemost; 1994 Oct; 72(4):503-7. PubMed ID: 7878623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient hypoplastic anemia caused by primary human parvovirus B19 infection in a previously untreated patient with hemophilia transfused with a plasma-derived, monoclonal antibody-purified factor VIII concentrate.
    Matsui H; Sugimoto M; Tsuji S; Shima M; Giddings J; Yoshioka A
    J Pediatr Hematol Oncol; 1999; 21(1):74-6. PubMed ID: 10029819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute transitory intrafamilial erythroblastopenia and hereditary spherocytosis: role of parvovirus B19].
    Granel B; Serratrice J; Rey J; David M; Pache X; Bernit E; Swiader L; Disdier P; Weiller PJ
    Rev Med Interne; 2001 Jul; 22(7):664-7. PubMed ID: 11508161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transmission of symptomatic parvovirus B19 infection by clotting factor concentrate.
    Yee TT; Cohen BJ; Pasi KJ; Lee CA
    Br J Haematol; 1996 May; 93(2):457-9. PubMed ID: 8639448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virus infection and clotting factor concentrates.
    Evans DI
    Lancet; 1995 May; 345(8959):1247-8. PubMed ID: 7739337
    [No Abstract]   [Full Text] [Related]  

  • 10. Parvovirus B19 and blood products.
    Prowse CV
    Lancet; 1994 Apr; 343(8905):1101. PubMed ID: 7909119
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence of antibodies against parvovirus B19 in Norwegians with congenital coagulation factor defects treated with plasma products from small donor pools.
    Rollag H; Patou G; Pattison JR; Degré M; Evensen SA; Fröland SS; Glomstein A
    Scand J Infect Dis; 1991; 23(6):675-9. PubMed ID: 1815327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human parvovirus B19 infection in hemophiliacs first infused with two high-purity, virally attenuated factor VIII concentrates.
    Azzi A; Ciappi S; Zakvrzewska K; Morfini M; Mariani G; Mannucci PM
    Am J Hematol; 1992 Mar; 39(3):228-30. PubMed ID: 1312304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parvovirus B19 and blood products.
    Guillaume T
    Lancet; 1994 Apr; 343(8905):1101. PubMed ID: 7909118
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence of IgG antibodies to human parvovirus B19 in haemophilia children treated with recombinant factor (F)VIII only or with at least one plasma-derived FVIII or FIX concentrate: results from the French haemophilia cohort.
    Gaboulaud V; Parquet A; Tahiri C; Claeyssens S; Potard V; Faradji A; Peynet J; Costagliola D;
    Br J Haematol; 2002 Feb; 116(2):383-9. PubMed ID: 11841442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parvovirus B19: A Cause of Sepsislike Syndrome in an Infant.
    Ugai S; Aizawa Y; Kanayama T; Saitoh A
    Pediatrics; 2018 Jun; 141(6):. PubMed ID: 29853623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parvovirus B19 antibodies in patients with haemophilia A.
    Peerlinck K; Goubau P; Reybrouck R; Desmyter J; Vermylen J
    Thromb Haemost; 1995 Mar; 73(3):555-6. PubMed ID: 7667846
    [No Abstract]   [Full Text] [Related]  

  • 17. Human parvovirus B19 in young male patients with hemophilia A: associations with treatment product exposure and joint range-of-motion limitation.
    Soucie JM; Siwak EB; Hooper WC; Evatt BL; Hollinger FB;
    Transfusion; 2004 Aug; 44(8):1179-85. PubMed ID: 15265122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parvovirus B19 transmission by heat-treated clotting factor concentrates.
    Blümel J; Schmidt I; Effenberger W; Seitz H; Willkommen H; Brackmann HH; Löwer J; Eis-Hübinger AM
    Transfusion; 2002 Nov; 42(11):1473-81. PubMed ID: 12421221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient erythroblastopenia due to human parvovirus B19 infection: a case report of a boy suffering from purpura.
    Miyata H; Yagi K; Takemura T; Maki S
    Acta Paediatr Jpn; 1994 Apr; 36(2):217-9. PubMed ID: 8203271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent B19 parvovirus infections in haemophilic HIV-1 infected patients.
    Musiani M; Zerbini M; Gentilomi G; Rodorigo G; De Rosa V; Gibellini D; Venturoli S; Gallinella G
    J Med Virol; 1995 Jun; 46(2):103-8. PubMed ID: 7636495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.